Description  Claims  Drawing  Cited references 

GB2456376A   [0029] 
WO2008155535A   [0029] 
US8846646B   [0030] 
GB1527638A   [0036] 
WO1998056390A   [0037] 
US3152039A   [0038] 
RU2227025   [0038] 
WO2008021088A   [0171] 

Arch Dis Child   [0005] 
Systematic review of Propionibacterium acnes resistance to systemic antibiotics   [0014] 
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris   [0014] 
J Am Acad. Dermatol.   [0014] 
Antimicrobial, Agents and Chemotherapy   [0023] 
Zentralbl. Mikrobiol.   [0024] 
the antibacterial activity of salicylanilides   [0025] 
Bioorganic and Medicinal Chemistry Letters   [0025] 
European Journal of Medicinal Chemistry   [0025] 
tested the antibacterial activity of closantel and related derivatives against the drug-resistant organisms, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF)   [0026] 
closantel had antibacterial activity against drug resistant S. aureus and E. faecium   [0027] 
identified closantel as a hit in a high throughput liquid screening assay and found anti-staphylococcal activity of closantel against vancomycin-resistant S. aureus isolates and other Gram-positive bacteria   [0028] 
Antimicrobial Agents and Chemotheer.   [0031] 
Int. J. Pharm.   [0034] 
Crystal Growth & Design   [0034] 
J. Agricultural and Food Chemistry   [0035] 
Int. Journal of Pharmaceutics   [0039] 
Handbook of Polymer Synthesis, Characterization, and Processing   [0105] 
Anal. Chem.   [0105] 
Methods in Enzymology   [0106] 
Design of Pro-drugs   [0106] 
A Textbook of Drug Design and Development   [0106] 
Design and Application of Pro-drugs   [0106] 
Advanced Drug Delivery Reviews   [0106] 
The Journal of Antimicrobial Chemotherapy   [0116] 
Gels handbook   [0152] 
Solubility and Solubilization in Aqueous Media   [0223] 
Skinmed   [0227] 
Percutaneous Penetration Enhancers   [0228] 
Handbook of Pharmaceutical Excipients   [0232] 
Cutaneous side effects of EGFR inhibitors-- appearance and management.   [0298] 
Pharmac. Ther.   [0327] 
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin   [0329] 
J. F. MacFaddin, Media for Isolation - Cultivation - Identification - Maintenance of Medical Bacteria   [0367] 
J. Basic Microbiol.   [0367] 
Medium for use in antibiotic susceptibility testing of anaerobic bacteria   [0367] 
Optimization of Periprosthetic Culture for Diagnosis of Propionibacterium acnes Prosthetic Joint Infection   [0367] 
Comparative In Vitro Activities of Retapamulin (SB-275833) against 141 Clinical Isolates of Propionibacterium spp., Including 117 P. acnes Isolates   [0367] 
Oecd, Test No. 428: Skin Absorption: In Vitro Method   [0401] 
Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers   [0401] 
Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis   [0407] 
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model   [0410] 
Antibacterial Agents and Chemotherapy   [0415] 
Acute Dermal Irritation/Corrosion   [0431]